COVID-19 Update | December 11, 2020

COVID-19 News

COVID-19 Update | December 11, 2020

December 11, 2020

The California Biotechnology Foundation is committed to keeping you up to date about COVID-19 testing, treatment and prevention advancements. The following resources track what progress has been made as of December 11, 2020. Notable advancements include:

  • Pfizer has received approval from the Food and Drug Administration advisory panel and could receive emergency use authorization as early as Friday.
  • AstraZeneca’s COVID-19 vaccine is safe and effective, according to a study from a peer-reviewed journal.
  • Moderna has dosed the first adolescents in a phase 2/3 clinical trial designed to position its COVID-19 vaccine for use in children as young as 12 years old.

​Recent News:

Rely on California Biotechnology Foundation to monitor breaking news and provide updates on the latest advancements in COVID-19 diagnostics, vaccines and treatments.

Stay informed on the latest news and trends on the economic and health benefits of this industry by visiting the new

If you have any questions about informational briefings contact California Biotechnology Foundation Executive Director Patty Cooper at (916)764-2434 or [email protected].